MCI1
MCID: MYC007
MIFTS: 79

Myocardial Infarction (MCI1) malady

Categories: Genetic diseases, Cardiovascular diseases

Aliases & Classifications for Myocardial Infarction

Aliases & Descriptions for Myocardial Infarction:

Name: Myocardial Infarction 54 38 12 29 52 42 14 69
Heart Attack 12 41 14
Myocardial Infarction 1 66 29
Myocardial Infarction, Protection Against 54
Myocardial Infarcation, Susceptibility to 13
Myocardial Infarction, Decreased 54
Premature Myocardial Infarction 66
Myocardial Infarcation 54
Myocardial Infarct 12
Mci1 66

Classifications:



External Ids:

OMIM 54 608446
Disease Ontology 12 DOID:5844
ICD10 33 I21 I22
MeSH 42 D009203
NCIt 47 C27996
UMLS 69 C0027051

Summaries for Myocardial Infarction

MedlinePlus : 41 each year over a million people in the u.s. have a heart attack. about half of them die. many people have permanent heart damage or die because they don't get help immediately. it's important to know the symptoms of a heart attack and call 9-1-1 if someone is having them. those symptoms include chest discomfort - pressure, squeezing, or pain shortness of breath discomfort in the upper body - arms, shoulder, neck, back nausea, vomiting, dizziness, lightheadedness, sweating these symptoms can sometimes be different in women. what exactly is a heart attack? most heart attacks happen when a clot in the coronary artery blocks the supply of blood and oxygen to the heart. often this leads to an irregular heartbeat - called an arrhythmia - that causes a severe decrease in the pumping function of the heart. a blockage that is not treated within a few hours causes the affected heart muscle to die. nih: national heart, lung, and blood institute

MalaCards based summary : Myocardial Infarction, also known as heart attack, is related to inferolateral myocardial infarct and pericarditis, and has symptoms including angina pectoris, chest pain and edema. An important gene associated with Myocardial Infarction is MIAT (Myocardial Infarction Associated Transcript (Non-Protein Coding)), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Transcriptional activation by NRF2. The drugs Abciximab and Everolimus have been mentioned in the context of this disorder. Affiliated tissues include Bone and Limb, and related phenotypes are cardiovascular system and hematopoietic system

Disease Ontology : 12 A coronary artery disease characterized by myocardial cell death (myocardial necrosis) due to prolonged ischaemia.

UniProtKB/Swiss-Prot : 66 Myocardial infarction 1: A condition defined by the irreversible necrosis of heart muscle secondary to prolonged ischemia.

Wikipedia : 71 Myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow stops to a part of... more...

Description from OMIM: 608446

Related Diseases for Myocardial Infarction

Diseases in the Myocardial Infarction family:

Myocardial Infarction 2 Acute Myocardial Infarction
Posterior Myocardial Infarction Myocardial Infarction, Susceptibility to, 1

Diseases related to Myocardial Infarction via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 429)
id Related Disease Score Top Affiliating Genes
1 inferolateral myocardial infarct 33.5 ACE PLAT
2 pericarditis 30.9 ACE OLR1 PLAT PON1 PTGIS
3 acute myocardial infarction 12.5
4 inferior myocardial infarction 12.3
5 anterolateral myocardial infarction 12.2
6 posterior myocardial infarction 12.2
7 silent myocardial infarction 12.2
8 anteroseptal myocardial infarction 12.2
9 lateral myocardial infarction 12.2
10 subendocardial myocardial infarction 12.2
11 acute anterolateral myocardial infarction 12.1
12 myocardial infarction 2 12.1
13 septal myocardial infarction 12.1
14 apical myocardial infarction 12.1
15 posterolateral myocardial infarction 12.1
16 posteroinferior myocardial infarction 12.1
17 acute inferolateral myocardial infarction 12.1
18 subendocardial infarction acute myocardial infarction 12.0
19 strictly posterior acute myocardial infarction 12.0
20 myocardial infarction, susceptibility to, 1 11.9
21 coronary artery disease, autosomal dominant, 1 11.6
22 coronary thrombosis 11.6
23 coronary artery disease 11.4
24 kawasaki disease 11.3
25 werner syndrome 11.1
26 ventricular fibrillation, familial, 1 10.9
27 acute inferoposterior infarction 10.9
28 hyperlipidemia type 3 10.9
29 coronary artery disease, autosomal dominant, 2 10.9
30 chronic mountain sickness 10.9
31 morbid obesity and spermatogenic failure 10.9
32 hyperlipidemia, familial combined 10.9
33 thrombophilia due to thrombomodulin defect 10.9
34 thrombocythemia 3 10.9
35 cardiogenic shock 10.6
36 thrombosis 10.6
37 artery disease 10.5
38 cardiac rupture 10.5
39 endotheliitis 10.5
40 aneurysm 10.5
41 cervix small cell carcinoma 10.5 ACE F7 PLAT PON1
42 pyrimidine metabolic disorder 10.4 ACE F7 PLAT PON1
43 angina pectoris 10.4
44 autoimmune-related retinopathy and optic neuropathy 10.4 ACE OLR1 PON1 PTGIS
45 right bundle branch block 10.4
46 bone development disease 10.4 F7 ITGB3 PLAT
47 heart disease 10.4
48 myocarditis 10.4
49 macular degeneration, age-related, 12 10.4 ACE F7 PLAT PON1
50 atherosclerosis 10.4

Graphical network of the top 20 diseases related to Myocardial Infarction:



Diseases related to Myocardial Infarction

Symptoms & Phenotypes for Myocardial Infarction

Clinical features from OMIM:

608446

UMLS symptoms related to Myocardial Infarction:


angina pectoris, chest pain, edema

MGI Mouse Phenotypes related to Myocardial Infarction:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.07 OLR1 PLAT PON1 PTGIS TNFSF4 ACE
2 hematopoietic system MP:0005397 9.85 ACE CXCL12 ESR1 F13A1 GUCY1A3 ITGB3
3 homeostasis/metabolism MP:0005376 9.8 ACE ESR1 F13A1 F7 GCLC GCLM
4 mortality/aging MP:0010768 9.4 ACE CXCL12 ESR1 F13A1 F7 GCLC

Drugs & Therapeutics for Myocardial Infarction

Drugs for Myocardial Infarction (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 923)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Abciximab Approved Phase 4,Phase 3,Phase 2 143653-53-6
2
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
3
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 22916-47-8 4189
4
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
5
Etanercept Approved, Investigational Phase 4,Phase 1,Phase 2 185243-69-0
6
Pravastatin Approved Phase 4,Phase 3,Phase 2 81093-37-0 54687
7
Colchicine Approved Phase 4,Phase 3,Phase 2 64-86-8 6167 2833
8
Ticagrelor Approved Phase 4,Phase 3,Phase 2,Phase 1 274693-27-5 9871419
9
Ticlopidine Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 55142-85-3 5472
10
Tirofiban Approved Phase 4,Phase 3,Phase 2,Phase 1 144494-65-5 60947
11
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 50-78-2 2244
12
Bivalirudin Approved, Investigational Phase 4,Phase 3,Phase 2 128270-60-0 16129704
13
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 9005-49-6 772 46507594
14
Tenecteplase Approved Phase 4,Phase 3,Phase 2 191588-94-0
15
Nicorandil Approved Phase 4,Phase 3 65141-46-0 47528
16
Eptifibatide Approved, Investigational Phase 4,Phase 3,Phase 2 188627-80-7 123610
17
Coal tar Approved Phase 4,Phase 2 8007-45-2
18
Chlorhexidine Approved, Vet_approved Phase 4 55-56-1 9552079 2713
19
Citalopram Approved Phase 4,Phase 2 59729-33-8 2771
20
Omeprazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1 73590-58-6 4594
21
Pantoprazole Approved Phase 4,Phase 3 102625-70-7 4679
22
Clonidine Approved Phase 4,Phase 3,Early Phase 1 4205-90-7 2803
23
Phenprocoumon Approved Phase 4,Phase 3 435-97-2 9908 54680692
24
Warfarin Approved Phase 4,Phase 2,Phase 3 81-81-2 6691 54678486
25
Celecoxib Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 169590-42-5 2662
26
Menthol Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 2216-51-5 16666
27
Cilostazol Approved Phase 4,Phase 3 73963-72-1 2754
28
Ramipril Approved Phase 4,Phase 3,Phase 2 87333-19-5 5362129
29
Telmisartan Approved, Investigational Phase 4,Phase 3,Phase 2 144701-48-4 65999
30
Acenocoumarol Approved Phase 4,Phase 3 152-72-7 9052 54676537
31
Salicylic acid Approved, Vet_approved Phase 4,Phase 3 69-72-7 338
32
Paclitaxel Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 33069-62-4 36314
33
Amiloride Approved Phase 4,Phase 3 2016-88-8, 2609-46-3 16231
34
Amlodipine Approved Phase 4,Phase 3,Phase 1,Phase 2,Early Phase 1 88150-42-9 2162
35
Simvastatin Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 79902-63-9 54454
36
Acarbose Approved, Investigational Phase 4,Phase 3,Phase 2 56180-94-0 441184
37
Methylprednisolone Approved, Vet_approved Phase 4,Phase 2 83-43-2 6741
38
Prednisolone Approved, Vet_approved Phase 4,Phase 2 50-24-8 5755
39
Rivaroxaban Approved Phase 4,Phase 2,Phase 3 366789-02-8
40
Ethanol Approved Phase 4,Phase 3,Early Phase 1 64-17-5 702
41
Insulin Glargine Approved Phase 4,Phase 3 160337-95-1
42
Metformin Approved Phase 4,Phase 2,Phase 3,Early Phase 1 657-24-9 14219 4091
43
Zinc Approved Phase 4,Phase 3,Phase 1 7440-66-6 32051 23994
44
Desflurane Approved Phase 4 57041-67-5 42113
45
Isoflurane Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 26675-46-7 3763
46
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2 2078-54-8 4943
47
Udenafil Approved, Investigational Phase 4 268203-93-6 6918523
48
Benzocaine Approved Phase 4,Phase 2,Phase 3,Phase 1 1994-09-7, 94-09-7 2337
49
Valsartan Approved, Investigational Phase 4,Phase 3,Phase 2 137862-53-4 60846
50
Acetylcholine Approved Phase 4,Phase 2,Phase 1 51-84-3 187

Interventional clinical trials:

(show top 50) (show all 4159)
id Name Status NCT ID Phase
1 Sirolimus Eluting Stenting in Acute Myocardial Infarction Unknown status NCT00288210 Phase 4
2 Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction Unknown status NCT01372930 Phase 4
3 Efficacy of Thrombosuction in Primary Percutaneous Coronary Intervention of Acute Myocardial Infarction Unknown status NCT01156662 Phase 4
4 Pravastatin for Acute Myocardial Infarction With Minimally to Mildly Increased Levels of Serum Cholesterol Study Unknown status NCT00688922 Phase 4
5 Thrombus Aspiration During Percutaneous Coronary Intervention in Acute Non-ST-elevation Myocardial Infarction Study Unknown status NCT01013038 Phase 4
6 Colchicine in ST-elevation Myocardial Infarction Unknown status NCT01936285 Phase 4
7 Randomized Trial of Standard vs ClearWay-infused Abciximab and Thrombectomy for Myocardial Infarction Unknown status NCT01499407 Phase 4
8 Early Routine Catheterisation After Alteplase Fibrinolysis vs. Primary PCI in Acute ST-elevation Myocardial Infarct Unknown status NCT01930682 Phase 4
9 Comparison of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial Function Unknown status NCT02123004 Phase 4
10 Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI Unknown status NCT00229515 Phase 4
11 Comparison of Primary PCI vs. Post-thrombolysis PCI as Reperfusion Strategies in STEMI Unknown status NCT02268669 Phase 4
12 Anti-Restenosis After AMI by Erythropoietin Unknown status NCT00423020 Phase 4
13 Efficacy Study of Combined Prasugrel and Bivalirudin Versus Clopidogrel and Heparin in Myocardial Infarction Unknown status NCT00976092 Phase 4
14 Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction. Unknown status NCT01080638 Phase 4
15 Microvascular Reperfusion Utilizing Sonothrombolysis in Acute Myocardial Infarction (MRUSMI TRIAL) Unknown status NCT02170103 Phase 4
16 IRIS : Use of Implantable Defibrillator in High-Risk Patients Early After Acute Myocardial Infarction Unknown status NCT00157768 Phase 4
17 Effects of Intensive Statin Treatment on Left Ventricular Function Unknown status NCT01936103 Phase 4
18 Effect of Nicorandil for the Patients of Acute ST Segment Elevation Myocardial Infarction Unknown status NCT02435797 Phase 4
19 Optimizing Infarct Size by Transforming Emergent Stenting Into an Elective Procedure Study Unknown status NCT01462188 Phase 4
20 Effect of Conditioning on Myocardial Damage in STEMI Unknown status NCT02158468 Phase 4
21 A Prospective, Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction Unknown status NCT01942070 Phase 4
22 Multivessel Stenting Versus Staged Revascularization With Zotarolimus-eluting Stent for STEMI Unknown status NCT01781715 Phase 4
23 Comparison of Biolimus A9 and Everolimus Drug-Eluting Stents in Patients With ST Segment Elevation Myocardial Infarction Unknown status NCT00888758 Phase 4
24 Bivalirudin/Prasugrel Versus Abciximab/Clopidogrel in Patients Presenting With STEMI Unknown status NCT01158846 Phase 4
25 Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin Unknown status NCT00370045 Phase 4
26 Coronary Angioplasty in Octogenarians With Emergent Coronary Syndromes Unknown status NCT02126202 Phase 4
27 Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome Unknown status NCT01372839 Phase 4
28 Cost-effectiveness of Genotype Guided Treatment With Antiplatelet Drugs in STEMI Patients: Optimization of Treatment Unknown status NCT01761786 Phase 4
29 MGuard Stent in ST-elevation Myocardial Infarction Unknown status NCT01124942 Phase 4
30 Randomized Trial of Creatine-kinase Leak After Rosuvastatin At the Time of Percutaneous Coronary Intervention Unknown status NCT01968577 Phase 4
31 Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI Unknown status NCT02233790 Phase 4
32 A Trial to Evaluate Efficacy of Heart-protecting Musk Pill Unknown status NCT01897805 Phase 4
33 Thrombus Aspiration for OcLuded Coronary Artery Enhanced With Distal Injection Of Abciximab Unknown status NCT01383785 Phase 4
34 N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure Unknown status NCT00692718 Phase 4
35 Local Thrombolytics Before Thrombectomy in STEMI Unknown status NCT01568931 Phase 4
36 the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery. Unknown status NCT02158559 Phase 4
37 Polish-Italian-Hungarian RAndomized ThrombEctomy Trial Unknown status NCT00377650 Phase 4
38 A Study to Evaluate Safety and Efficacy of the ExcelTM Sirolimus Eluting Stent With a Biodegradable Polymer Versus Sirolimus Eluting Stent With Non-Biodegradable Polymer in the Treatment of Patients With de Novo Coronary Artery Lesions Unknown status NCT00825773 Phase 4
39 Dissecting the Role of Distal Embolization of Athero-thrombotic Material in Primary PCI: the ThrombOticBurden and mIcrovAscularobStruction (TOBIAS) Study. Unknown status NCT01914055 Phase 4
40 Treating Acute MI Patients With Aggrastat on Their Way to Hospital Unknown status NCT00300833 Phase 4
41 HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study) Unknown status NCT00106886 Phase 4
42 Post-MI PET Scan Imaging of Inflammation Unknown status NCT02281305 Phase 4
43 DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome Unknown status NCT00140257 Phase 4
44 Comparing Ticagrelor and Clopidogrel Pharmacodynamics After Thrombolysis Unknown status NCT02048085 Phase 4
45 Zotarolimus and Everolimus-Eluting Stents ProsPectively Compared in Real World Unknown status NCT00768846 Phase 4
46 Assessment of Coronary Flow Reserve by Doppler Flow WIre in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Differences Between the Loading Dose of Prasugrel and Ticagrelor . Unknown status NCT02032303 Phase 4
47 Efficacy of Xience/Promus Versus Cypher in rEducing Late Loss After stENTing Unknown status NCT00698607 Phase 4
48 Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN) Unknown status NCT01735227 Phase 4
49 EPIC (Evaluating Perioperative Ischemia Reduction by Clonidine) Unknown status NCT00335582 Phase 4
50 Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside) Unknown status NCT00963781 Phase 4

Search NIH Clinical Center for Myocardial Infarction

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Myocardial Infarction cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Myocardial Infarction:
ADRCs, adipose-derived regenerative cells for cardiovascular disease
AMI MultiStem
AMR-001, bone marrow-derived CD34+ cells for myocardial infarction
Autologous bone marrow-derived mononuclear cells for myocardial infarction
Bone marrow or peripheral blood-derived stem cells for treatment of myocardial ischemia
Bone marrow-derived adult mononuclear cells for heart diseases
Bone marrow-derived CD133+ vs. mononuclear cells for treatment of myocardial infarction
Bone marrow-derived mesenchymal stem cells for treatment of myocardial ischemia
Bone marrow-derived mononuclear cells for acute myocardial infarction
Bone marrow-derived mononuclear cells for chronic myocardial infarction
Bone marrow-derived mononuclear cells for myocardial infarction
Bone marrow-derived mononuclear cells for myocardial infarction
Bone marrow-derived mononuclear cells for myocardial infarction
Bone marrow-derived mononuclear cells for treatment of myocardial infarction
Bone marrow-derived progenitor cells for myocardial infarction
Bone marrow-derived stem cells for treatment of ischemic cardiomyopathy
Cardiosphere-derived autologous stem cells for reverse ventricular dysfunction
Cardiosphere-derived cells for the treatment of myocardial infarction
CD133+ bone marrow-derived stem cells in conjuction with coronary artery bypass grafting
Combination therapy of mononuclear cells with laser for coronary disease
Early endothelial progenitor cells for acute myocardial infarction
Embryonic stem cell-derived cardiomyocyte transplantation for myocardial infarction
Embryonic stem cell-derived cardiomyocytes for treatment of myocardial infarction
Enriched bone marrow-derived progenitor cells for heart diseases
Hearticellgram
Hydrogels with cardiomyocytes for myocardial repair
Induced pluripotent stem cells for treatment of myocardial infarction
itMSC, bone marrow-derived mesenchymal stem cells for cardiovascular diseases
Mesenchymal precursor cells for cardiovascular diseases
Mesendo, stem cell combination for treatment of cardiovascular diseases
MyoCell
Prochymal
Sca-1-positive cardiac progenitor cells for treatment of myocardial infarction
Stem cell therapy for treatment of acute myocardial infarction
StempeucelAMI
Umbilical cord blood-derived CD133 positive cells for treatment of myocardial infarction
Embryonic/Adult Cultured Cells Related to Myocardial Infarction:
Adipose-derived stem and regenerative cells PMIDs: 21082397 22281257
Bone marrow-derived adherent progenitor cells (MultiStem) PMIDs: 23111647 22004910 22052917 21175285
Bone marrow-derived autologous CD34+cells (AMR-001) PMIDs: 21167340
Bone marrow-derived mononuclear cells PMIDs: 19002124
Bone marrow-derived mononuclear cells
Peripheral blood-derived hematopoietic stem cells (family)
Bone marrow-derived mononuclear cells PMIDs: 22137069 19699857 20445812 20524773
Bone marrow-derived CD133+ hematopoietic stem cells
Bone marrow-derived mononuclear cells (family) PMIDs: 16889856 16382259 22192151 21414223 21392602 22940024
Bone marrow-derived mesenchymal stem cells (family)
Bone marrow-derived mononuclear cells
Bone marrow-derived mesenchymal stem cells PMIDs: 16889856 16382259
Bone marrow-derived mononuclear cells PMIDs: 22834565
Bone marrow-derived mononuclear cells PMIDs: 22834565
Bone marrow-derived mononuclear cells
Bone marrow-derived progenitor cells PMIDs: 20448133 16159812 18293890
Porcine bone marrow-derived mesenchymal stem cells PMIDs: 21392602 22940024 19958962
Bone marrow-derived mesenchymal stem cells PMIDs: 21392602 22940024
Cardiosphere-derived cells PMIDs: 22336189 17283259
Bone marrow-derived CD133+ cells PMIDs: 17320570
Peripheral blood-derived endothelial progenitor cells PMIDs: 21362705 22239631
eNOS-transfected endothelial progenitor cells PMIDs: 21362705 22239631
Cardiomyocyte-like cells PMIDs: 17980256 21783246
Cardiomyocyte-like cells PMIDs: 22040108
Bone marrow-derived progenitor cells PMIDs: 23362308 22936827 18794392 16990384 16990385 22651868
Neonatal rat ventricular cardiomyocytes PMIDs: 21783246
DR4 induced pluripotent stem cells PMIDs: 23568891
Mesenchymal Precursor Cells (STRO-3 selected) PMIDs: 20850099 21155976
Bone marrow-derived mesenchymal stem cells PMIDs: 21323410 20631864
Bone marrow-derived mononuclear cells PMIDs: 21323410 20631864
Skeletal myoblasts (MyoCell PMIDs: 19051139 15615560 16446778
Bone marrow-derived mesenchymal stem cells PMIDs: 19958962
Cardiac progenitor cells (Sca1+) PMIDs: 21980409
Bone marrow-derived CD34+/CXCR4+ cells
Bone marrow-derived mesenchymal stem cells (Stempeucel PMIDs: 18720444
Umbilical cord blood-derived CD133+ cells PMIDs: 16195418

Cochrane evidence based reviews: myocardial infarction

Genetic Tests for Myocardial Infarction

Genetic tests related to Myocardial Infarction:

id Genetic test Affiliating Genes
1 Myocardial Infarction 1 29
2 Myocardial Infarction 29

Anatomical Context for Myocardial Infarction

MalaCards organs/tissues related to Myocardial Infarction:

39
Heart, Bone, Endothelial, Brain, Lung, Testes, Monocytes
LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Myocardial Infarction:
id Tissue Anatomical CompartmentCell Relevance
1 Bone Bone Marrow Bone Marrow Stromal Cells Potential therapeutic candidate
2 Limb Pelvic Girdle Bone Marrow Stromal Cells Potential therapeutic candidate
3 Heart Myocardium Cardiomyocytes Affected by disease

Publications for Myocardial Infarction

Articles related to Myocardial Infarction:

(show top 50) (show all 7042)
id Title Authors Year
1
Impact of Morning Onset on the Incidence of Recurrent Acute Coronary Syndrome and Progression of Coronary Atherosclerosis in Acute Myocardial Infarction. ( 28090071 )
2017
2
Rationale and Design of a Clinical Trial to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human CARdiac stEm Cells in Patients with Acute Myocardial Infarction and Left Ventricular Dysfunction: The Randomized Multicenter Double-Blind Controlled CAREMI Trial. ( 28533209 )
2017
3
Outcomes in Patients Undergoing PrimaryA Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Via Radial Access Anticoagulated With Bivalirudin VersusA Heparin: A Report From the National Cardiovascular Data Registry. ( 28527778 )
2017
4
The Impact of tagSNPs in CXCL16 Gene on the Risk of Myocardial Infarction in a Chinese Han Population. ( 28286356 )
2017
5
Benefits of Statin Therapy in Patients With Acute Myocardial Infarction With Serum Low-Density Lipoprotein Cholesterol a8o 50A mg/dl. ( 28532771 )
2017
6
Influences of IL-1b-3953 C>T and MMP-9-1562Ca88>T Gene Variants on Myocardial Infarction Susceptibility in a Subset of the Iranian Population. ( 27824519 )
2017
7
Cardiac remodeling following reperfused acute myocardial infarction is linked to the concomitant evolution of vascular function as assessed by cardiovascular magnetic resonance. ( 28063459 )
2017
8
Inferior Wall Acute Myocardial Infarction: Not as Preload Dependent as Once Thought? ( 28089058 )
2017
9
Fast assessment and management of chest pain patients without ST-elevation in the pre-hospital gateway (FamouS Triage): ruling out a myocardial infarction at home with the modified HEART score. ( 28084079 )
2017
10
Letter by Koh Regarding Article, "Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial". ( 28069716 )
2017
11
Ventricular Septal Defect Complicating ST-Elevation Myocardial Infarctions: A Call for Action. ( 28065768 )
2017
12
Circulating MicroRNA-145 is Associated with Acute Myocardial Infarction and Heart Failure. ( 28051023 )
2017
13
Plasma apelin-12 levels may predict in-hospital major adverse cardiac events in ST-elevation myocardial infarction and the relationship between apelin-12 and the neutrophil/lymphocyte ratio in patients undergoing primary coronary intervention. ( 27770057 )
2017
14
Moving Beyond SHOCK: New Paradigms in the Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock. ( 28024554 )
2017
15
CRP velocity and short-term mortality in ST segment elevation myocardial infarction. ( 28055283 )
2017
16
Pirfenidone controls the feedback loop of the AT1R/p38 MAPK/renin-angiotensin system axis by regulating liver X receptor-I+ in myocardial infarction-induced cardiac fibrosis. ( 28091615 )
2017
17
Correlation of Ventricular Arrhythmogenesis with Neuronal Remodeling of Cardiac Postganglionic Parasympathetic Neurons in the Late Stage of Heart Failure after Myocardial Infarction. ( 28533740 )
2017
18
Cardiac Troponin T: Smaller Molecules in Patients with End-Stage Renal Disease than after Onset of Acute Myocardial Infarction. ( 28073901 )
2017
19
Trimethylamine N-oxide and Risk Stratification after Acute Myocardial Infarction. ( 28062632 )
2017
20
Prognostic Implications of Mid-Range Left Ventricular Ejection Fraction on Patients Presenting With ST-Segment Elevation Myocardial Infarction. ( 28532775 )
2017
21
Association of Rapid Care Process Implementation on Reperfusion Times Across Multiple ST-Segment-Elevation Myocardial Infarction Networks. ( 28082714 )
2017
22
Incidence of atrial fibrillation detected by continuous rhythm monitoring after acute myocardial infarction in patients with preserved left ventricular ejection fraction: results of the ARREST study. ( 28069838 )
2017
23
The potential of optimizing prehospital triage of patients with suspected acute myocardial infarction using high-sensitivity cardiac troponin T and copeptin. ( 27903076 )
2017
24
Does This Patient Have Acute Myocardial Infarction? ( 28062638 )
2017
25
Outcomes of patients with myocardial infarction who underwent orbital atherectomy for severely calcified lesions. ( 28529094 )
2017
26
Analysis of reperfusion time trends in patients with ST-elevation myocardial infarction across New York State from 2004 to 2012. ( 28082097 )
2017
27
A Common Variant in SCN5A and the Risk of Ventricular Fibrillation Caused by First ST-Segment Elevation Myocardial Infarction. ( 28085969 )
2017
28
Modest Improvement of Reperfusion Times Across Multiple ST-Segment-Elevation Myocardial Infarction Networks With Rapid Care Process Implementation but no Effect on Mortality. ( 28082715 )
2017
29
Changes in One-Year Mortality in Elderly Patients Admitted with Acute Myocardial Infarction in Relation with Early Management. ( 28065766 )
2017
30
Epicardial collaterals spasm as a cause of ST elevation myocardial infarction. ( 28092292 )
2017
31
Clinical outcomes in myocardial infarction and multivessel disease after a cardiac rehabilitation programme: Partial versus complete revascularization. ( 28082243 )
2017
32
Evaluating the role of autologous mesenchymal stem cell seeded on decellularized pericardium in the treatment of myocardial infarction: an animal study. ( 28528367 )
2017
33
Correlation and prognostic role of neutrophil to lymphocyte ratio and SYNTAX score in patients with acute myocardial infarction treated with percutaneous coronary intervention: A six-year experience. ( 28529092 )
2017
34
Factors associated with compliance to AHA/ACC performance measures in a myocardial infarction system of care in Brazil. ( 28531328 )
2017
35
Cardiac and Noncardiac Causes of Long-Term Mortality in ST-Segment-Elevation Acute Myocardial Infarction Patients Who Underwent Primary Percutaneous Coronary Intervention. ( 28073848 )
2017
36
Prognostic impact of residual SYNTAX score in patients with ST-elevation myocardial infarction and multivessel disease: Analysis of an 8-year all-comers registry. ( 28532984 )
2017
37
History of erectile dysfunction as a predictor of poor physical performance after an acute myocardial infarction. ( 28067536 )
2017
38
ST segment elevation myocardial infarction caused by post-traumatic coronary artery perforation. ( 28530027 )
2017
39
Lymphocytic myocarditis occurs with myocardial infarction and coincides with increased inflammation, hemorrhage and instability in coronary artery atherosclerotic plaques. ( 28087177 )
2017
40
The mitochondria-targeting peptide elamipretide diminishes circulating HtrA2 in ST-segment elevation myocardial infarction. ( 28534645 )
2017
41
Mesenchymal Stem Cells with eNOS Over-Expression Enhance Cardiac Repair in Rats with Myocardial Infarction. ( 27913896 )
2017
42
Prognostic value of total triiodothyronine and free thyroxine levels for the heart failure in patients with acute myocardial infarction. ( 28073241 )
2017
43
Effects of neuregulin GGF2 (cimaglermin alfa) dose and treatment frequency on left ventricular function in rats following myocardial infarction. ( 27993643 )
2017
44
Long-term outcome and risk prediction in patients suffering acute myocardial infarction complicated by post-infarction cardiac rupture. ( 27847155 )
2017
45
Expression pattern of genome-scale long noncoding RNA following acute myocardial infarction in Chinese Uyghur patients. ( 28418905 )
2017
46
Response by Heydari et al to Letter Regarding Article, "Effect of Omega-3 Acid Ethyl Esters on Left Ventricular Remodeling After Acute Myocardial Infarction: The OMEGA-REMODEL Randomized Clinical Trial". ( 28069718 )
2017
47
Wild-type p53-induced Phosphatase 1 Deficiency Exacerbates Myocardial Infarction-induced Ischemic Injury. ( 28524834 )
2017
48
COLIN trial: Value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response. ( 28065445 )
2017
49
Antiplatelet Therapy and Clinical Outcomes Following Myocardial Infarction Among Patients in a U.S. Employer-Based Insurance Database. ( 28530518 )
2017
50
Effect of Post-procedural Full Does Infusion of Bivalirudin on Acute Stent Thrombosis in Patients with ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Outcomes in a large real-world population. ( 28083915 )
2017